Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. NATtrol Controls
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

NATtrol Controls

[0131-LC1505] Lung squamous cell carcinoma tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores(1.0mm), fresh cut, unstained
Lung squamous cell carcinoma tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores(1.0mm), fresh cut, unstained
366.00 € 366.0 EUR
[0245-KronosDio-repair-1] Kronos Dio repair service (thermocontrol issue)
Kronos Dio repair service (thermocontrol issue)
4,850.00 € 4850.0 EUR
[0297-K73C-4M] Insulin Control	L1, L2:  2 x 0.5mL each, lyophilized
Insulin Control L1, L2: 2 x 0.5mL each, lyophilized
232.00 € 232.0 EUR
[0002-NATFLURSV-6C] Influenza/RSV Positive Control (6 x 0.5 mL)
Influenza/RSV Positive Control (6 x 0.5 mL)
344.00 € 344.0 EUR
[0002-KZMC033] Influenza Rapid Test Control Pack - 3 X 1.5mL
Influenza Rapid Test Control Pack - 3 X 1.5mL
371.00 € 371.0 EUR
[0002-NATFLUB-ERCL] Influenza B Low External Run Control (6 x 1mL)
Influenza B Low External Run Control (6 x 1mL)
456.00 € 456.0 EUR
[0002-NATFLUAB-6C-IVD] Influenza A/B Positive Control 6 X 0.5 mL
Influenza A/B Positive Control 6 X 0.5 mL
354.00 € 354.0 EUR
[0002-NATFLUAB-6MC] Influenza A/B Positive Control (6 X 0.5 mL)
Influenza A/B Positive Control (6 X 0.5 mL)
572.00 € 572.0 EUR
[0002-NATFLUAH1-ERCM] Influenza A H1, External Run Control, Medium (6 x 1mL)
Influenza A H1, External Run Control, Medium (6 x 1mL)
523.00 € 523.0 EUR
[0508-IR101.3prong] Infinity Rocker Pro	  Laboratory rocker designed for extra long life with digital speed control.  11 x 14 in. (28 x 36 cm) platform
Infinity Rocker Pro Laboratory rocker designed for extra long life with digital speed control. 11 x 14 in. (28 x 36 cm) platform
2,025.00 € 2025.0 EUR
[0868-C183] INTROL® BCR-ABL1 p190 Control Panel, 10 x 4 mL
INTROL® BCR-ABL1 p190 Control Panel, 10 x 4 mL
1,218.00 € 1218.0 EUR
[0399-CSB-PA314851XA01SZB] Rabbit anti-Shigella flexneri secD: Custom made, Deliverables: 200ug. antigen (positive control) + 1ml Pre-immune serum (negative control) + 10mG. antibodies purified by Protein A/G
Rabbit anti-Shigella flexneri secD: Custom made, Deliverables: 200ug. antigen (positive control) + 1ml Pre-immune serum (negative control) + 10mG. antibodies purified by Protein A/G
2,050.00 € 2050.0 EUR
[0800-N1001-100ug.] Rabbit Isotype Control Polyclonal Antibody, 100ug., 0.5 mG./ml antibody in PBS with 0.05% sodium azide
Rabbit Isotype Control Polyclonal Antibody, 100ug., 0.5 mG./ml antibody in PBS with 0.05% sodium azide
410.00 € 410.0 EUR
[0002-NATRSV-6C-IVD] RSV Respiratory Syncytial Virus Positive Control CE IVD (6 x 0.5 mL)
RSV Respiratory Syncytial Virus Positive Control CE IVD (6 x 0.5 mL)
364.20 € 364.2 EUR
[0002-MDZ001] RP Multimarker Control Pack - 6 X 0.75 mL
RP Multimarker Control Pack - 6 X 0.75 mL
744.00 € 744.0 EUR
[0868-M360v1.2] QIAstat-Dx RP SARS-CoV-2 Control Panel - 12 x 300 μL
QIAstat-Dx RP SARS-CoV-2 Control Panel - 12 x 300 μL
920.00 € 920.0 EUR
[0868-M475] QIAstat-Dx GI2 Control Panel - 12 tubes * 200 µL
QIAstat-Dx GI2 Control Panel - 12 tubes * 200 µL
976.00 € 976.0 EUR
[0173-430-080] PrPrice RSV Control Swab Test (Global), 10 tests/Test
PrPrice RSV Control Swab Test (Global), 10 tests/Test
52.00 € 52.0 EUR
[676-TC-9082-PC] Positive Control for TC-9082/EZ-PED/TGE/PDCoV MPX 1.1 Master Mix and Enzyme
Positive Control for TC-9082/EZ-PED/TGE/PDCoV MPX 1.1 Master Mix and Enzyme
225.00 € 225.0 EUR
[0220-PCR-705] Pork Genomic DNA Positive control - 20 µg
Pork Genomic DNA Positive control - 20 µg
145.00 € 145.0 EUR
  • 2
  • 3
  • 4
  • 5
  • 6

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)